1. ICH guideline S7A Safety pharmacology studies for human pharmaceuticals;Anon,2001
2. ICH guideline S7B the non-clinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolognation) by human pharmaceuticals;Anon,2005
3. ICH guideline M3(R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals;Anon,2009